Fifth Third Bancorp Oncolytics Biotech Inc Transaction History

Fifth Third Bancorp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.85 - $1.59 $8,500 - $15,900	-10,000 Reduced 90.91%	1,000 $1,000
Q1 2022 Apr 19, 2022	BUY	$1.31 - $2.02 $13,100 - $20,200	10,000 Added 1000.0%	11,000 $17,000
Q1 2020 May 05, 2020	BUY	$0.98 - $4.28 $980 - $4,280	1,000 New	1,000 $1,000

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.